Colorectal cancer screening with fecal occult blood test: A 22-year cohort study

Oncology Letters

Volumn 6, Issue 2, 2013, Pages 576-582

  Jin, Peng ^a,b   Wu, Zi Tao ^a   Li, Shi Rong ^a   Li, Shu Jun ^a   Wang, Ji Heng ^a   Wang, Zhi Hong ^a   Lu, Jian Guo ^a   Cui, Xin Juan ^a   Han, Ying ^a   Rao, Jianyu ^c,d   Sheng, Jian Qiu ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Colorectal cancer; Fecal occult blood test; Screening

Indexed keywords

ADENOMA; ADULT; AGED; ARTICLE; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; ECHOGRAPHY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HUMAN; IMMUNOCHEMISTRY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; MORTALITY; OCCULT BLOOD TEST; QUESTIONNAIRE; RISK FACTOR; THORAX RADIOGRAPHY;

EID: 84879468794     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1402     Document Type: Article

References (16)

1. Stewart BW and Kleihues P: World cancer report. Lyon: IARC Press: 163-166, 2003.
2. Zhang SW, Chen WQ, Kong LZ, Li LD, Lu FZ, Li GL, Meng J and Zhao P: An analysis of cancer incidence and mortality from 30 cancer registries in China, 1998~2002. Zhongguo Zhongliu 15: 430-448, 2006.
3. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, JohnsonCD, et al; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee: Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134: 1570-1595, 2008.
4. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM and Ederer F: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328: 1365-1371, 1993.
5. Kronborg O, Fenger C, Olsen J, Jorgensen OD and SøndergaardO: Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348: 1467-1471, 1996.
6. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, AmarSS, Balfour TW, James PD and Mangham CM: Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348: 1472-1477, 1996.
7. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, CuffT, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF and Selby JV: Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 99: 1462-1470, 2007.
8. Allison JE, Tekawa IS, Ransom LJ and Adrain AL: A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 334: 155-159, 1996.
9. Li S, Nie Z, Li N, Li J, Zhang P, Yang Z, Mu S, Du Y, Hu J, YuanS, Qu H et al: Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study. Chin Med J (Engl) 116: 200-202, 2003.
10. Li S, Wang H, Hu J, Li N, Liu Y, Wu Z, Zheng Y, Wang H, WuK, Ye H and Rao J: New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: Results of a prospective multicenter study in Chinese patients. Int J Cancer 118: 3078-3083, 2006.
11. Wong BC, Wong WM, Cheung KL, Tong TS, Rozen P, YoungGP, Chu KW, Ho J, Law WL, Tung HM, Lai KC, Hu WH, ChanCK and Lam SK: A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population. Aliment Pharmacol Ther 18: 941-946, 2003.
12. Calogne N, Petitti DB, DeWitt TG, Dietrich AJ, Gregory KD, Harris R, Isham G, LeFevre ML, Leipzig RM, Loveland-Cherry C, Marion LN et al; U.S. Preventive Services Task Force: Screening for colorectal cancer: U.S. Preventie Services Task Force recommendation statement. Ann Intern Med 149: 627-637, 2008.
13. Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S; Japan Public Health Center-based Prospective Study: Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan. Cancer Detect Prev 31: 3-11, 2007.
14. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, MonginSJ, Snover DC and Schuman LM: The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343: 1603-1607, 2000.
15. van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, FockensP, van Krieken HH, Verbeek AL, Jansen JB and DekkerE: Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135: 82-90, 2008.
16. Niv Y, Lev-El M, Fraser G, Abuksis G and Tamir A: Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers. Gut 50: 33-37, 2002.